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Subcellular targeting and local translation of mRNAs
are critical for axon development. However, the pre-
cise local control of mRNA translation requires inves-
tigation. We report that the Fmr1-encoded protein,
FMRP-mediated axonal delivery of miR-181d nega-
tively regulates axon elongation by locally targeting
the transcripts of MAP1B (Map1b) and calmodulin
(Calm1) in primary sensory neurons. miR-181d
affected the local synthesis of MAP1B and calmod-
ulin in axons. FMRP was associated with miR-181d,
Map1b, and Calm1. Both FMRP deficiency in
Fmr1I304N mice and Fmr1 knockdown impeded the
axonal delivery of miR-181d, Map1b, and Calm1
and reduced the protein levels of MAP1B and
calmodulin in axons. Furthermore, nerve growth fac-
tor (NGF) induced Map1b and Calm1 release from
FMRP and miR-181d-repressing granules, thereby
promoting axon elongation. Both miR-181d overex-
pression and FMRP knockdown impaired NGF-
induced axon elongation. Our study reveals a
mechanism for the local regulation of translation by
miR-181d and FMRP during axon development.
INTRODUCTION
Neurons have specialized cellular structures that include den-
drites and axons. SomemRNAs are known to traffic to dendrites
and axons for local protein synthesis in response to rapid extra-
cellular signals that are involved in neuronal differentiation, syn-
apse formation, and axon growth during neuronal development
(Jung et al., 2012; Lin and Holt, 2008). The molecular mecha-
nisms underlying the regulation of local protein synthesis have
been investigated. Recently, a class of non-coding small RNA2794 Cell Reports 13, 2794–2807, December 29, 2015 ª2015 The Aumolecules, microRNAs (miRNAs), has been revealed to regulate
mRNA stability and translation and to play important roles in a
variety processes, including the development of the nervous
system (Fineberg et al., 2009; McNeill and Van Vactor, 2012).
Previous studies have reported the existence of a distinct popu-
lation of miRNAs in the axons of primary sensory neurons
located in the dorsal root ganglion (DRG) and that loss of Dicer,
which produces mature miRNAs, resulted in defective peripheral
nerve projections (Hancock et al., 2014). However, further func-
tions and mechanisms of axonal miRNAs in the development of
axons in primary sensory neurons require investigation.
RNA binding proteins (RBPs) have been implicated as cyto-
skeletal adaptors that act via a form of ribonucleoprotein (RNP)
granules that carry mRNAs into the dendrite or axon (Dictenberg
et al., 2008; Lin and Holt, 2008). FMRP is an RBP that is encoded
by Fmr1, the absence of which causes dysregulated neuronal
disorders, includingmental retardation and autism spectrumdis-
orders (Bassell and Warren, 2008; Cheever and Ceman, 2009).
Several reports provide solid evidence showing that FMRP con-
trols protein synthesis by regulatingmRNA stability or repressing
protein synthesis by directly binding target genes in an activity-
dependent manner (Bassell and Warren, 2008; Wang et al.,
2008). FMRP is also reported to be associated with mRNAs in
the RNA-induced silencing complex (RISC) and to thereby
potentially be involved in the miRNA-mediated regulation of ac-
tivity-dependent protein synthesis (Muddashetty et al., 2011).
Despite the role that FMRP plays in the trafficking of postsyn-
aptic transcripts (Dictenberg et al., 2008), whether FMRP medi-
ates the transport of miRNAs or FMRPmediates the regulation of
local protein synthesis by miRNAs in response to extracellular
signals in axons remains unexplored.
In our study, by using a microfluidic culture of embryonic DRG
neurons, we identified the relative enrichment of miR-181d in
axons. miR-181d affected axon elongation by locally targeting
the mRNAs of microtubule-associated protein 1B (MAP1B) and
calmodulin, a crucial regulator of calcium signaling. FMRP was
associated with miR-181d and its targets MAP1B mRNAthors
(Map1b) and calmodulin mRNA (Calm1). The downregulation of
FMRP in Fmr1I304N mice or in the cell bodies of cultured DRG
neurons impaired the axonal delivery of miR-181d with Map1b
and Calm1, leading to decreased protein levels of MAP1B and
calmodulin in axons. Furthermore, nerve growth factor (NGF)
increased the local synthesis of MAP1B and calmodulin in axons
by releasing Map1b and Calm1 from FMRP and miR-181d-re-
pressing granules. Thus, we reveal a mechanism for axon elon-
gation by the FMRP-mediated axon delivery of miR-181d and
its associated mRNAs and local regulation of protein synthesis.
RESULTS
miR-181d Is Enriched in Axons of Embryonic DRG
Neurons
To assess the distribution of miRNAs in axons, we used a micro-
fluidic device containing separate cell body and axon compart-
ments to culture DRG neurons (Figure S1A) (Chen et al., 2012).
The DAPI signal was observed only in the cell body compart-
ment, whereas the Tuj-1-positive signal was observed in both
the cell body and the axon compartments (Figure 1A). RT-PCR
also showed that g-actin was restricted to cell bodies, but
b-actin and Impa1, the transcript of a key enzyme that is crucial
for axonal maintenance, were observed in both the cell bodies
and the axons of cultured embryonic day 13.5 (E13.5) DRG neu-
rons (Figure S1B), consistent with previous reports (Andreassi
et al., 2010). Furthermore, immunoblotting from the microfluidic
cultures of DRG neurons detected MAP2 only in cell bodies,
while Tau-1 was distributed in both cell bodies and axons (Fig-
ure S1C). These results thus confirm that the RNA and protein
that were prepared from the axons of DRG neurons were devoid
of nuclear components from the cell bodies, further indicating
the successful compartmental culture of DRG neurons.
Previous studies have demonstrated the importance of the
Dicer-dependent miRNA pathway in sensory axon development
and peripheral nerve regeneration (Hancock et al., 2014). We
measured the amount of miRNA that was downregulated in the
DRGs of the Dicer knockout mice (Zhao et al., 2010) in the cell
bodies and axons of DRG neurons at E13.5. Quantitative real-
time PCR (qPCR) showed that miR-181d was abundant in the
axons of DRG neurons (Figures 1A and S1D). In situ hybridization
using a lock nucleic acid (LNA)-modified specific probe showed
that the miR-181d signal was present in both cell bodies
and axons in punctate structures compared to the low signal
of the scramble probe (Figure 1B). These data suggest that
miR-181d is enriched and localized in axons of embryonic
DRG neurons.
Map1b and Calm1 Are Targeted by Axon-Enriched
miR-181d in DRG Neurons
To identify the possible downstream targets of miR-181d, bio-
informatic tools including TargetScan and miRanda were used
to analyze the axonal pool of thousands of mRNAs from the
large-scale sequencing of developing and adult sensory neurons
(Gumy et al., 2011). Nine candidate genes that were predicted by
these software packages were selected (Figure S1E). To de-
termine which genes might be regulated by miR-181d, we
performed luciferase reporter assays in HEK293 cells after suc-Cell Repcessful transfection of a miR-181d inhibitor and its mimics in
cultured E13.5 DRG neurons (Figure S1F). The overexpression
of miR-181d with its mimics significantly decreased the 30 un-
translated region (UTR) activity of Map1b and Calm1 but not of
their mutants, which lost the ability to be bound by miR-181d
(Figures 1C, S1G, and S1H). However, the overexpression of
miR-497, which was not detected in the axons of sensory neu-
rons (Hancock et al., 2014), did not affect the 30 UTR activity of
Map1b and Calm1 (Figure S1I), demonstrating that the silencing
pathway was not simply overloaded with exogenously ex-
pressed miRNAs. These data suggest that Map1b and Calm1
are potential targets of miR-181d.
Although the transcript of MAP1B has been shown to localize
in neurons, including dendrites and axons (Antar et al., 2006; Dic-
tenberg et al., 2008), the distribution pattern of the MAP1B and
calmodulin transcripts remains to be described in embryonic
DRG neurons. RT-PCR showed the presence of Map1b and
Calm1 in both the cell body and the axon compartments of mi-
crofluidic cultured E13.5 DRG neurons (Figure 1D). In situ hybrid-
ization further detected the granular appearance of Map1b and
Calm1 expression in the cell bodies and axons of cultured
E13.5 DRG neurons (Figure 1E). We also successfully monitored
the 30 UTR transport of mRNAs using the MS2 system (Fusco
et al., 2003), in which the b-actin-30 UTR, but not the g-actin-30
UTR, was detected in axons (Figure S1K). Plasmid transfection
was performed on cultured post-natal day 14 (P14) DRG neu-
rons, which are more resistant to electroporation than are
E13.5 DRG neurons. The granules containing Map1b-30 UTR
and Calm1-30 UTR were clearly observed and moved bidirec-
tionally in the axons of cultured P14 DRG neurons (Figures 1F
and 1G). These data verify the axonal localization and trafficking
of MAP1B and calmodulin transcripts in DRG neurons.
Furthermore, we assessed the protein levels of MAP1B and
calmodulin in cultured E13.5 DRG neurons. Immunoblotting
showed that the upregulation or downregulation of miR-181d
bidirectionally regulated the protein level of MAP1B and calmod-
ulin in cultured DRG neurons (Figures 1H and 1I), whereas qPCR
showed no significant change in the levels of those mRNAs (Fig-
ure S1J), suggesting that miR-181d mediates the repression of
MAP1B and calmodulin post-transcriptionally. However, the
application of a miR-181d inhibitor and its mimics did not affect
the protein level of b-actin, and the transfection of miR-497
mimics did not decrease the protein level ofMAP1B and calmod-
ulin in cultured E13.5 DRG neurons (Figures S2A–S2D). Taken
together, these data suggest that axon-enriched miR-181d spe-
cifically targets Map1b and Calm1 in DRG neurons.
miR-181d Regulates Axon Elongation by Affecting the
Local Synthesis of MAP1B and Calmodulin
The transport and local translation of mRNA are essential
for axon development (Jung et al., 2012). MAP1B stabilizes
the cytoskeleton during the elongation of central and peripheral
axons in DRG neurons (Dajas-Bailador et al., 2012; Montenegro-
Venegas et al., 2010). Calmodulin mediates calcium signaling,
which is involved in growth cone guidance and dendrite growth
in the central nervous system (CNS) (McCue et al., 2010). There-
fore, the miR-181d-mediated regulatory machinery might play a
role in axon development in primary sensory neurons. Weorts 13, 2794–2807, December 29, 2015 ª2015 The Authors 2795
Figure 1. Identification of Axon-Enriched miR-181d and Its Targets, Map1b and Calm1, in Embryonic DRG Neurons
(A) miR-181d was enriched in the axons of embryonic DRG neurons. Immunostaining for Tuj-1 demonstrated the successful establishment of microfluidic
cultured E13.5 DRG neurons at 7 DIV (upper panel). A qPCR analysis of miR-181d showed a 5.4-fold increase in its axonal abundance compared to the cell
bodies. The results are presented as mean ± SEM. *p < 0.05 versus the level of miR-181d in the cell body (n = 6). Scale bar, 300 mm.
(B) Localization of miR-181d (red) in the axons and cell bodies of E13.5 DRG neurons at 4 DIV used LNA-modified probes. A scramble probe was used as the
negative control. Immunostaining for Tuj-1 (green) indicated the neuronal profile. Scale bar, 5 mm.
(C) Luciferase reporter assays showed thatMap1b andCalm1 are potential downstream targets of miR-181d. The luciferase activity of theWT 30 UTR, but not the
mutatedMap1b andCalm1, was downregulated by miR-181d mimics in HEK293 cells. The results are presented as mean ± SEM. *p < 0.05 and **p < 0.01 versus
the negative control (n = 3).
(D) RT-PCR showed that Map1b and Calm1 were distributed in the cell bodies and axons of cells in the microfluidic cultures of E13.5 DRG neurons at 7 DIV.
b-actin and g-actin were the positive and negative controls, respectively, for axonal distribution.
(E) In situ hybridization showed thatMap1b and Calm1 (red) were localized in the cell bodies and axons of cultured E13.5 DRG neurons at 4 DIV. Immunostaining
for tubulin (green) was used to indicate the neuronal profile. Scale bar, 5 mm.
(F and G) Live-cell imaging demonstrated the anterograde movement of Map1b-30 UTR (F) and Calm1-30 UTR (G) in the axons of cultured P14 DRG neurons at
4 DIV (arrowheads). Scale bar, 5 mm.
(H and I) Immunoblotting showed that applying a miR-181d inhibitor (H) and its mimics (I) increased and decreased, respectively, the protein levels of MAP1B and
calmodulin in cultured E13.5 DRG neurons at 4 DIV. Tubulin was used as a loading control. The results are presented as mean ± SEM. *p < 0.05 and **p < 0.01
versus the negative control (n = 3).
See also Figures S1 and S2.
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Figure 2. miR-181d Negatively Regulates Axon Elongation by Locally Targeting Axonal Map1b and Calm1
(A and B) Representative images of microfluidic cultured E13.5 DRG axons at 4 DIV (A) and quantitative results of axon growth rates (B) showed that the axonal
application of a miR-181d inhibitor and its mimics increased and decreased axon elongation, respectively, in the microfluidic chamber. The results are presented
as mean ± SEM. *p < 0.05 versus the negative control (n = 3). Scale bar, 300 mm.
(legend continued on next page)
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successfully performed RNA transfection selectively in axons
(Figures S2E and S2F) and began by detecting the effect of
miR-181d on axon elongation. In microfluidic cultures of E13.5
DRG neurons in the presence of 100 ng/ml NGF, which kept
normal neuron growth, knockdown of miR-181d by a specific in-
hibitor in the axon compartment significantly increased the axon
growth rate, whereas overexpression of miR-181d by its mimics
strongly decreased the axon growth rate (Figures 2A and 2B). In
a control experiment, we showed that overexpression of miR-
497 by its mimics did not affect the axon growth rate (Figures
S2G and S2H). Thus, miR-181d has a regulatory effect on axon
elongation.
We then evaluated the local synthesis of MAP1B and calmod-
ulin in the presence of small interfering RNA (siRNA)-mediated
knockdown of MAP1B and calmodulin in axons. In cultured
E13.5 DRG neurons, transfection with siRNA dramatically
reduced the endogenous expression levels of both MAP1B and
calmodulin (Figures 2C and 2D). The application of siRNA exclu-
sively in the axon compartment for 48 hr significantly decreased
the axon growth rate by knocking down axonal MAP1B or
calmodulin (Figures 2E and 2F), suggesting that the axonal syn-
thesis of MAP1B and calmodulin contributes to axon elongation.
Finally, to determine whether the effect of miR-181d on axon
elongation involved the local translation of Map1b and Calm1,
we used the synthesized and LNA-modified target protector
(TP) to disrupt the interaction between miR-181d and Map1b
or Calm1 (Figure S3A) (Staton and Giraldez, 2011). Transfection
with 50 nM Map1b-TP and Calm1-TP markedly increased the
protein levels of MAP1B and calmodulin (Figures S3B and
S3C), whereas the levels of Map1b and Calm1, as well as the
level of miR-181d, remained unchanged (Figure S3D). Moreover,
the expression of Map1b-TP in the axon compartment signifi-
cantly increased the amount of MAP1B but not the amount of
calmodulin, whereas the expression of Calm1-TP increased
the axonal synthesis of calmodulin but not that of MAP1B (Fig-
ure 2G). Using either Map1b-TP or Calm1-TP resulted in an in-
crease in axon elongation (Figures 2H and 2I). Taken together,
these data suggest that miR-181d regulates axon elongation
by affecting the local synthesis of MAP1B and calmodulin.
FMRP Is Associated with miR-181d, Map1b, and Calm1
RBPs mediate mRNA localization and translation in the inverte-
brate and mammalian nervous systems (Jung et al., 2012).
Because the MAP1B mRNA has been shown to associate with(C and D) Representative immunoblots and quantitative data showed that si-Map1
cultured E13.5 DRG neurons at 4 DIV. Tubulin was used as a loading control. The
control. **p < 0.01 versus the siRNA control (n = 3).
(E and F) Representative images of microfluidic cultured E13.5 DRG axons at 4 D
application of si-Map1b or si-Calm1 reduced axon elongation. The results are pre
300 mm.
(G) Representative immunoblots and quantitative data showed that the axonal app
30 UTR ofMap1b orCalm1, respectively, and increased the protein levels of MAP1
E13.5 DRG neurons at 4 DIV. Tubulin was used as a loading control. The results ar
**p < 0.01 versus the negative control (n = 3).
(H and I) Representative images of microfluidic cultured E13.5 DRG axons at 4 D
axonal application of eitherMap1b-TP or Calm1-TP increased axon elongation in
versus the negative control (n = 3). Scale bar, 300 mm.
See also Figures S2 and S3.
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axons of neurons (Antar et al., 2006; Zalfa et al., 2003), we as-
sessed the interaction of miR-181d and its targets with FMRP
in P14 rat tissue of DRGs by performing co-immunoprecipitation
using an FMRP antibody (Figure 3A). The qPCR showed that
miR-181d, but not miR-9 or miR-132, was enriched in the
FMRP-precipitated immunoprecipitates of DRG extracts (Fig-
ure 3B). In addition, RT-PCR showed that Map1b and Calm1
were co-immunoprecipitated by FMRP, aswas Fmr1 (Figure 3C).
To confirm a specific association betweenmiR-181d and FMRP,
we used a control—another RBP, cytoplasmic polyadenylation
element-binding protein 1 (CPEB1), that binds to a specific cyto-
plasmic polyadenylation element sequence in the 30 UTR of its
targets. Pheochromocytoma 12 (PC12) cells contain endoge-
nous miR-181d, MAP1B, and calmodulin, and they are a good
model system for detecting the association between FMRP
and miR-181d, Map1b, and Calm1. We performed immunopre-
cipitation using a FLAG-tagged antibody in PC12 cells express-
ing FMRP-GFP-FLAG or CPEB1-GFP-FLAG (Figure 3D). The
qPCR showed abundant miR-181d in the immunoprecipitates
pulled down by FMRP-GFP-FLAG but not in those pulled down
by CPEB1-GFP-FLAG (Figure 3E). However, miR-9 did not
interact with FMRP-GFP-FLAG or CPEB1-GFP-FLAG (Fig-
ure 3E). We found that FMRP-GFP-FLAG, but not CPEB1-
GFP-FLAG, immunoprecipitated endogenous Map1b and
Calm1 (Figure 3F). In addition, the interaction of FMRP with
Map1b andCalm1was not dependent onmiRNA-181d, because
knockdown of miRNA-181d by its inhibitor did not affect their as-
sociation (Figures S4A and S4B). Therefore, these data provide
biochemical evidence showing that FMRP associates with
miR-181d, Map1b, and Calm1.
We further explored the axonal co-localization of FMRP with
miR-181d, Map1b, and Calm1. Immunostaining for FMRP com-
bined with in situ hybridization forMap1b or Calm1 showed that
these endogenous mRNAs were localized in the FMRP-positive
granules in the axons of cultured P14 DRG neurons and approx-
imately 53% of Map1b-positive granules and 36% of Calm1-
positive granules contained FMRP (Figures 3G and 3H). In situ
hybridization for miR-181d, combined with immunostaining for
FMRP, showed that approximately 42% miRNA-181d-positive
granules contained FMRP (Figures 3G and 3H), and miR-181d
was localized in approximately 27% FMRP granules containing
Map1b-30 UTR and approximately 25%FMRPgranules express-
ing Calm1-30 UTR in the axons of cultured P14 DRG neuronsb and si-Calm1 decreased the protein levels ofMAP1B (C) and calmodulin (D) in
results are presented as mean ± SEM and normalized to the levels in the siRNA
IV (E) and quantitative results of axon growth rates (F) showed that the axonal
sented as mean ± SEM. *p < 0.05 versus the siRNA control (n = 3). Scale bar,
lication ofMap1b-TP orCalm1-TP blocked the interaction ofmiR-181dwith the
B and calmodulin in the axon, but not in the cell body, in microfluidic cultures of
e presented as mean ± SEM and normalized to the mock control. *p < 0.05 and
IV (H) and quantitative results of axon growth rates (I) demonstrated that the
the microfluidic chamber. The results are presented as mean ± SEM. *p < 0.05
thors
Figure 3. FMRP Is Associated with miR-
181d, Map1b, and Calm1
(A) Immunoblotting showed the products of
immunoprecipitation by a FMRP antibody in P14
DRGs. Immunoglobulin G (IgG) served as a con-
trol.
(B) A qPCR analysis showed that miR-181d, but
not miR-9, miR-132, or U6, was abundant in the
FMRP immunoprecipitates of P14 DRGs. The re-
sults are presented as mean ± SEM. *p < 0.05
versus the IgG control (n = 3).
(C)Map1b and Calm1 were detected in the FMRP
immunoprecipitates of P14 DRGs using RT-PCR.
Fmr1, which is known to be associated with
FMRP, was used as a positive control.Gapdhwas
used as a negative control.
(D) Immunoblots showing the immunoprecipitates
that were pulled down by a FLAG antibody in PC12
cells expressing FMRP-GFP-FLAG or CPEB1-
GFP-FLAG. Tubulin or IgG served as the loading
control.
(E) A qPCR analysis showing that miR-181d was
abundant in the FMRP but not the CPEB1 immu-
noprecipitates of PC12 cells. The results are pre-
sented as mean ± SEM. *p < 0.05 versus PC12
cells expressing GFP (n = 3).
(F) Map1b and Calm1 were significantly detected
in the FLAG immunoprecipitates from PC12 cells
expressing FMRP-GFP-FLAG, but not those ex-
pressing CPEB1-GFP-FLAG, using RT-PCR. Fmr1
was used as the positive control for an association
with FMRP, and Gapdh was used as the negative
control.
(G and H) Representative images (G) and quanti-
tative results (H) showed co-localization between
miR-181d, Map1b, or Calm1 (red) and FMRP
(green) in the axons of cultured P14 DRG neurons
at 4 DIV (arrowheads). The results are presented
as mean ± SEM (n = 3). Scale bar, 10 mm.
(I and J) Representative images (I) and quantitative
results (J) showed miR-181d (green) co-localized
with FMRP (blue) and Map1b-30 UTR or Calm1-30
UTR (red) in the axons of cultured P14 DRG neu-
rons at 4 DIV (arrowheads). The results are pre-
sented as mean ± SEM (n = 3). Scale bar, 10 mm.
See also Figure S4.(Figures 3I and 3J). Taken together, our data suggest that FMRP
associates with miR-181d, Map1b, and Calm1 in DRG neurons.
FMRP Deficiency Causes Defects in the Axonal Delivery
of miR-181d, Map1b, and Calm1
We assessed the function of FMRP in the axonal distribution of
miR-181d, Map1b, and Calm1 in vivo. The qPCR showed thatCell Reports 13, 2794–2807, Dethe levels of miR-181d, Map1b, and
Calm1 were lower in the sciatic nerves,
but not in the DRGs, of Fmr1I304N mice
at P14 than in those of wild-type (WT)
mice (Figures 4A and 4B). We also used
an adeno-associated virus (AAV) 2/8-
mediated technique to knockdown
FMRP in the cell bodies of microfluidiccultured E13.5 DRG neurons (Figures 4C and 4D). Seven days af-
ter AAV-shFMRP-GFP-FLAG infection of cell body compart-
ments, immunoblotting showed dramatically decreased protein
levels of FMRP in both cell bodies and axons (Figures 4C and
4D), suggesting a high efficiency of knockdown by the AAV.
The mRNA of FMRP (Fmr1) was rarely detected in the axons of
cultured E13.5 DRG neurons, which is consistent with a previouscember 29, 2015 ª2015 The Authors 2799
report (Gumy et al., 2011). The qPCR showed that the expression
levels of miR-181d,Map1b, andCalm1 in the axons of DRG neu-
rons were decreased, whereas their expression in the cell bodies
remained unchanged (Figure 4E). Furthermore, we transfected
MS2-mCherry withMap1b-30 UTR orCalm1-30 UTR into cultured
P14 DRG neurons expressing either FMRP short hairpin RNA
(shRNA) or a control shRNA. Knockdown of FMRP reduced the
numbers ofMap1b-30 UTR and Calm1-30 UTR granules in axons
showing either anterograde or retrograde movement, in addition
to increasing the number of granules showing non-significant
movement—whether stationary, Brownian, or otherwise not
showing displacement over long distances (Figures 4F–4H).
However, the average anterograde and retrograde velocities of
Map1b-30 UTR and Calm1-30 UTR granules were not changed
(Figure 4I). Co-expression of shRNA-resistant FMRP (FMRPR)
rescued the axonal transport of Map1b-30 UTR and Calm1-30
UTR granules by silencing FMRP (Figures 4F–4H), indicating
that the defect caused by FMRP shRNA was not due to an off-
target effect. In addition, phase contrast images showed that
the DRG neurons affected by knockdown of FMRP by either
AAV infection or electroporation displayed morphologies similar
to those of neurons that were transfected with control shRNA
(Figures S5A and S5B), which excluded the effect of significant
stress in neurons affected by FMRP shRNA. As a control,
b-actin-30 UTR was not localized in the FMRP-GFP-positive
granules, and the axonal transport of b-actin-30 UTR was unaf-
fected by knockdown of FMRP (Figures S5C–S5F), suggesting
the specificity of FMRP-mediated mRNA transport. Thus,
FMRP is required for the axonal delivery of miR-181d, Map1b,
and Calm1.
FMRPDeficiency Decreases the Protein Level ofMAP1B
and Calmodulin
We further assessed the protein levels of MAP1B and calmod-
ulin in the FMRP-deficient axons of DRG neurons. Consistent
with a previous report (Zang et al., 2009), we found that the
protein level of FMRP was dramatically reduced in the DRGs
and sciatic nerves of the Fmr1I304N mice (Figures 5A and 5B).
We then showed that Fmr1I304N mice had decreased levels of
MAP1B and calmodulin in sciatic nerves, whereas the levels
of these proteins in DRGs were unchanged (Figures 5A and
5B). In microfluidic cultures of E13.5 DRG neurons infected
with AAV-shFMRP-GFP-FLAG, the amounts of MAP1B and
calmodulin in the axon compartment were significantly reduced
(Figures 5C and 5D). Co-expression of AAV-FMRPR-mCherry-
FLAG rescued the decrease in the protein level of FMRP in
the cell bodies and axons of cultured E13.5 DRG neurons
induced by silencing FMRP (Figures 5C and 5D). The protein
levels of MAP1B and calmodulin, which were reduced by
silencing FMRP in axons, were markedly recovered by expres-
sion of FMRPR (Figures 5C and 5D). However, the protein levels
of MAP1B and calmodulin in the cell bodies of cultured E13.5
DRG neurons were not affected by the knockdown or rescue
of FMRP (Figure 5D). Furthermore, the stability and protein
transport of MAP1B and calmodulin were not affected by
silencing FMRP because the protein levels of MAP1B and
calmodulin in cell bodies remained stable (Figure 5), and the
fluorescence recovery after photobleaching (FRAP) of2800 Cell Reports 13, 2794–2807, December 29, 2015 ª2015 The AuMAP1B-GFP and calmodulin-GFP in axons was unchanged
(Figures S5G–S5I). Taken together, these results suggest that
the defects in the axonal delivery of mRNAs caused by FMRP
deficiency influence the protein levels of MAP1B and calmod-
ulin in the axons of DRG neurons.
NGF Triggers the Release of Map1b and Calm1 from
FMRP Granules
Previous studies have shown that FMRP is a repressor of the
transcripts that it binds and that their association can be affected
by extrinsic signaling (Muddashetty et al., 2011). Given evidence
supporting the FMRP-mediated axonal delivery ofmiR-181d and
its targets, we next explored whether signals regulate their asso-
ciation with FMRP granules. NGF plays a critical role in axon
growth during the development of primary sensory neurons
because more than 80% of neurons express its receptor, tropo-
myosin receptor kinase A (TrkA), at E13.5 (White et al., 1996). To
test the role of NGF, 5 ng/ml NGF was replaced to only maintain
basal survival in microfluidic cultured DRG neurons for 12 hr.
Treatment of the axon compartment with 100 ng/ml NGF for
2 hr significantly increased the protein levels of MAP1B and
calmodulin in axons without affecting their levels in the cell
bodies of microfluidic cultured E13.5 DRG neurons (Figures 6A
and 6B). This increase was blocked by co-treatment of the
axon compartment with cycloheximide (CHX), an inhibitor of pro-
tein synthesis (Figures 6A and 6B), which suggests the locally
induced translation of Map1b and Calm1 by NGF. Neurotro-
phin-3 (NT-3) was unable to induce the axonal translation of
Map1b and Calm1 (Figures S6A and S6B), suggesting that the
effect of local NGF signaling on the protein synthesis of
MAP1B and calmodulin is specific. These data suggest that
NGF signaling promotes the local synthesis of MAP1B and
calmodulin in axons.
We then explored whether local NGF signaling regulates the
levels of miR-181d, Map1b, and Calm1 in axons. Surprisingly,
we found that miR-181d, Map1b, and Calm1 levels remained
unchanged in both cell bodies and axons after NGF was
applied to the axon compartment (Figures 6C and 6D). We hy-
pothesize that NGF signaling may affect the association of
FMRP with miR-181d and its targets. Therefore, we performed
co-immunoprecipitation experiments to detect the interaction
between FMRP and miR-181d, Map1b, and Calm1 in response
to NGF. PC12 cells endogenously express high levels of the re-
ceptor TrkA, and they express miR-181d, Map1b, and Calm1.
In PC12 cells exogenously expressing FMRP-GFP-FLAG, the
amount of Map1b and Calm1 co-immunoprecipitated by a
FLAG antibody was significantly decreased after treatment
with 100 ng/ml NGF for 2 hr, whereas the amount of co-immu-
noprecipitated Fmr1 was not changed (Figures 6E and 6F).
However, the level of miR-181d that was associated with
FMRP was not altered in the presence of 100 ng/ml NGF (Fig-
ure 6G). Furthermore, the association of the P body component
argonaute 2 (Ago2) with FMRP-GFP-FLAG was not affected by
NGF treatment in PC12 cells (Figures 6H and 6I). Taken
together, these results show that NGF triggers the release of
Map1b and Calm1 from FMRP granules, leading to the escape
of Map1b and Calm1 from translational inhibition by FMRP and
miR-181d.thors
Figure 4. FMRP Deficiency Impairs Axonal Targeting of miR-181d, Map1b, and Calm1
(A and B) A qPCR analysis showed that miR-181d (A), as well asMap1b andCalm1 (B), was decreased in the sciatic nerves, but not in the DRGs, of P14 Fmr1I304N
mice. The results are presented as mean ± SEM. *p < 0.05 and **p < 0.01 versus the WT (n = 5).
(C) Schematic of the AAV-shFMRP-GFP-FLAG construct used for FMRP knockdown.
(D) A representative image showed highly efficient infection of AAV-shFMRP-GFP-FLAG in a microfluidic culture of E13.5 DRG neurons at 7 DIV (upper panel).
Immunoblotting revealed significant reductions in FMRP in the cell bodies and axons (lower panel). Scale bar, 300 mm.
(E) A qPCR analysis showed that miR-181d, Map1b, and Calm1 were decreased in the axons, but not in the cell bodies, of microfluidic cultured E13.5 DRG
neurons expressing AAV-shFMRP-GFP-FLAG at 7 DIV. The results are presented as mean ± SEM. *p < 0.05 and **p < 0.01 versus the control (Ctrl) shRNA (n = 4).
(legend continued on next page)
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Figure 5. FMRP Deficiency Reduces the
Levels of MAP1B and Calmodulin in the
Axons of DRG Neurons
(A and B) Representative immunoblots (A) and
quantitative data (B) showed that levels of MAP1B
and calmodulin were decreased in the sciatic
nerves, but not in the DRGs, of P14 Fmr1I304N mice.
FMRP was dramatically decreased in both DRGs
and sciatic nerves in Fmr1I304Nmice. The results are
presented as mean ± SEM. *p < 0.05 and **p < 0.01
versus the WT (n = 5).
(C and D) Representative immunoblots (C) and
quantitative data (D) showed that infection with
AAV-shFMRP-GFP-FLAG decreased the protein
levels of MAP1B and calmodulin in the axons, but
not in the cell bodies, of microfluidic cultured E13.5
DRG neurons at 7 DIV. These phenotypes were
partially rescued by co-expression of AAV-FMRP-
mCherry-FLAG (FMRPR). The results are presented
as mean ± SEM. *p < 0.05 and **p < 0.01 versus the
control (Ctrl) shRNA, and #p < 0.05 and ##p < 0.01
versus the indicated treatments (n = 3).
See also Figure S5.miR-181d and FMRP Are Involved in NGF-Induced Axon
Elongation byRegulating the Local Translation ofMap1b
and Calm1
Because NGF signaling regulated the association of Map1b
and Calm1 with miR-181d and FMRP, we next investigated
the functional role of miR-181d in NGF-induced axon elonga-
tion. After axonal application of 100 ng/ml NGF for 2 hr, we
observed that the axon growth rate was faster than that
observed under the basal condition of 5 ng/ml NGF in microflui-
dic cultures of E13.5 DRG neurons (Figures 7A and 7B). Trans-
fection of miR-181d mimics into the axon compartment of
microfluidic cultures of DRG neurons significantly attenuated
the NGF-induced axon elongation (Figures 7A and 7B). Mean-
while, immunoblotting showed that overexpressing miR-181d
mimics in axons blocked the NGF-induced local synthesis of
MAP1B and calmodulin in axons (Figures 7C and 7D). Although
axons lack Fmr1, we also excluded the possibility of a role for
miR-181d in the regulation of FMRP expression. Immunoblot-
ting showed that overexpression of miR-181d by its mimics
did not affect the level of FMRP in cultured E13.5 DRG neurons
(Figures S7A and S7B).
We then explored the functional role of FMRP in NGF-induced
axon elongation. In microfluidic cultures of E13.5 DRG neurons
infected with AAV-shFMRP-GFP-FLAG, knockdown of FMRP
did not change the axon growth rate in the presence of a low(F–I) Representative live-cell images (F and G) and quantitative data (H) showed
Map1b-30 UTR and Calm1-30 UTR granules (red) moving in both anterograde and
non-significant movement in the axons of cultured P14 DRG neurons at 4 DIV. Th
Mean velocity of anterograde and retrograde movements by Map1b-30 UTR and
collected, and a kymograph was created to demonstrate themovement ofMap1b
*p < 0.05 and **p < 0.01 versus the Ctrl shRNA, and #p < 0.05 and ##p < 0.01 ve
See also Figure S5.
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that basal axon elongation in DRG neurons is not mediated by
FMRP. Knockdown of FMRP significantly reduced the increase
in axon growth rate that was induced by 100 ng/ml NGF for
2 hr (Figures 7E and 7F). Meanwhile, the NGF-induced local
translation of Map1b and Calm1 in axons was abolished in
microfluidic cultures of E13.5 DRG neurons infected with
AAV-shFMRP-GFP-FLAG (Figures 7G and 7H). Taken together,
these data suggest that miR-181d and FMRP mediate NGF-
induced axon elongation by regulating the axonal translation of
Map1b and Calm1.
DISCUSSION
The role of miRNAs is critical in the translational control of local
mRNAs during axon development (Hancock et al., 2014; Ka-
plan et al., 2013). Here, we demonstrated that axon-enriched
miR-181d contributes to axon elongation by regulating the
local translation of Map1b and Calm1. miR-181d, together
with Map1b and Calm1, is associated with FMRP in primary
sensory neurons. FMRP deficiency impaired the axonal deliv-
ery of miR-181d with Map1b and Calm1 and thereby
decreased the protein levels of MAP1B and calmodulin in
axons. Moreover, NGF signaling triggers the release of
Map1b and Calm1 from FMRP granules, leading to the escapethat knockdown of FMRP by FMRP shRNA (green) reduced the numbers of
retrograde directions, as well as increasing the number of granules displaying
ese phenotypes were rescued by co-expression of FMRPR-BFP-FLAG (blue).
Calm1-30 UTR granules was not significantly changed (I). A 300 s video was
-30 UTR andCalm1-30 UTR granules. The results are presented asmean ±SEM.
rsus the indicated treatments (n = 3). Scale bar, 10 mm.
thors
Figure 6. NGF Signaling Regulates the As-
sociation of Map1b and Calm1 with FMRP
(A and B) Representative immunoblots (A) and
quantitative data (B) showed that axonal MAP1B
and calmodulin were increased after 2 hr of NGF
treatment in the axon compartment of microfluidic
cultured E13.5 DRG neurons at 7 DIV. These
phenotypes were abolished in the presence of
CHX. Tubulin was used as a loading control. The
results are presented as mean ± SEM. *p < 0.05
versus vehicle, and #p < 0.05 and ##p < 0.01 versus
the indicated treatments (n = 3).
(C and D) A qPCR analysis showed that miR-181d
(C), as well as Map1b and Calm1 (D), levels were
not changed in either cell bodies or axons after 2 hr
of NGF treatment in the axon compartment of
microfluidic cultured E13.5 DRG neurons at 7 DIV.
The results are presented as mean ± SEM (n = 3).
(E and F) RT-PCR (E) and qPCR analysis (F)
showed that the association ofMap1b and Calm1
with FMRP was decreased in the FLAG immuno-
precipitates after NGF treatment in PC12 cells
expressing FMRP-GFP-FLAG. The results are
presented as mean ± SEM. *p < 0.05 versus
vehicle (n = 4).
(G) A qPCRanalysis showed that the association of
miR-181dwithFMRPwasnotaffected, asanalyzed
in FLAG immunoprecipitates, by NGF treatment in
PC12 cells expressing FMRP-GFP-FLAG. The re-
sults are presented as mean ± SEM (n = 4).
(H and I) Representative immunoblots (H) and
quantitative data (I) showed that the association of
FMRP with Ago2 was not affected by NGF treat-
ment in PC12 cells expressing FMRP-GFP-FLAG.
The results are presented as mean ± SEM (n = 3).
See also Figure S6.of Map1b and Calm1 from translational inhibition by miR-181d
and FMRP. Thus, we have revealed a mechanism for FMRP-
mediated axonal delivery of miR-181d and its targets and local
regulation of Map1b and Calm1 translation in response to NGF
signaling.
Axon-Enriched miR-181d Negatively Regulates Axon
Elongation in Primary Sensory Neurons
The spatiotemporal distribution of mRNAs and miRNAs is
important for the functions of nervous systems (Fineberg et al.,
2009; Jung et al., 2012; Kaplan et al., 2013). In our study, by us-
ing microfluidic cultures of E13.5 DRG neurons and qPCR, we
dissected the relatively abundant miR-181d in axons from
downregulated miRNAs in the primary sensory neurons of Dicer
knockout mice. Recent studies have demonstrated the
presence of miR-181a in the axons of cortical neurons (Sasaki
et al., 2014) and miR-181d in the neurites of depolarizedCell Reports 13, 2794–2807, Dehuman neuroblast cells (Goldie et al.,
2014). High-throughput sequencing of
RNAs immunoprecipitated by an Ago2
antibody showed that members of the
miR-181 family were enriched in the brain
(Chi et al., 2009). Despite reports that
miR-181a in neurons is involved in syn-aptic plasticity (Saba et al., 2012) and cerebral ischemia
(Ouyang et al., 2012), the functions of the miR-181 family in
axon development, and the mechanisms underlying those func-
tions, are far from clear.
In microfluidic cultures of E13.5 DRG neurons, the applica-
tion of a miR-181d inhibitor to the axon compartment increased
axon elongation, whereas treatment with miR-181d mimics had
the opposite effect. Using bioinformatic predictions derived
from published axonal transcriptomes (Gumy et al., 2011), we
screened out Map1b and Calm1 as downstream targets of
miR-181d, suggesting the possibility that miR-181d negatively
regulates axonal elongation by influencing the stabilization of
microtubules and the activation of calcium signaling. In the
CNS, Map1b has been reported to localize to the dendrites
and axons of cortical neurons, and the local synthesis of
MAP1B has been found to contribute to axon guidance, elon-
gation, and neuronal migration via its effects on the stabilizationcember 29, 2015 ª2015 The Authors 2803
Figure 7. miR-181d and FMRP Are Involved
in NGF-Induced Axon Elongation by Regu-
lating Map1b and Calm1 Translation
(A and B) Representative phase contrast images
(A) and quantitative results of axon growth rates (B)
demonstrated that axon elongation was promoted
by 2 hr of treatment with NGF in the axon
compartment of microfluidic cultured E13.5 DRG
neurons at 4 DIV. This phenotypewas abolished by
the pre-application of miR-181d mimics in axons.
The results are presented as mean ± SEM. *p <
0.05 versus vehicle, and #p < 0.05 versus the
indicated treatment (n = 4). Scale bar, 10 mm.
(C and D) Representative immunoblots (C) and
quantitative data (D) showed that the NGF-induced
increase of MAP1B and calmodulin in axons was
abolished by the pre-application of miR-181d
mimics in the axon compartment of microfluidic
cultured E13.5 DRG neurons at 7 DIV. The results
are presented as mean ± SEM. *p < 0.05 versus
vehicle, and #p < 0.05 and ##p < 0.01 versus the
indicated treatment (n = 3).
(E and F) Representative images (E) and quantita-
tive results of axon growth rates (F) demonstrated
that the knockdown of FMRP by AAV-shFMRP-
GFP-FLAG decreased NGF-induced axon elon-
gation in microfluidic cultured E13.5 DRG neurons
at 7 DIV. The results are presented as mean ±
SEM. **p < 0.01 versus the control (Ctrl) shRNA,
and #p < 0.05 versus the indicated treatment
(n = 3). Scale bar, 10 mm.
(G and H) Representative immunoblots (G)
and quantitative data (H) showed that FMRP
knockdown by AAV-shFMRP-GFP-FLAG abol-
ished the NGF-induced increases in MAP1B and
calmodulin in the axons of cultured E13.5 DRG
neurons at 7 DIV. The results are presented as
mean ± SEM. *p < 0.05 and **p < 0.01 versus
vehicle (n = 3).
See also Figure S7.of microtubules (Montenegro-Venegas et al., 2010; Villarroel-
Campos and Gonzalez-Billault, 2014). The local role of calmod-
ulin-mediated calcium signaling has been investigated in axon
development (Nakamuta et al., 2011); however, our data
demonstrating the axonal distribution of Calm1 in fluorescence
in situ hybridization and the transport of Calm1-30 UTR in live-
cell imaging are the evidence to support the presence of
Calm1 in axons. The selective knockdown of miR-181d or the
blockade of the interacting domain of Map1b and Calm1 with
miR-181d in the axon compartment increased local levels of
MAP1B and calmodulin and promoted axon elongation, sug-
gesting a physiological role for miR-181d in the axons of pri-
mary sensory neurons.
A recent study has also reported that miR-132 is abundant in
the axons of sensory neurons and that it promotes axon
extension by targeting the mRNA of the Ras guanosine tri-
phosphatase activator Rasa1 (Hancock et al., 2014). Consid-
ering that miR-181d negatively regulates axon elongation by
affecting Map1b and Calm1 translation, our data demon-
strating that different miRNAs cooperatively affect axon elon-
gation by targeting different downstream molecules are
interesting.2804 Cell Reports 13, 2794–2807, December 29, 2015 ª2015 The AuFMRP Mediates the Axonal Delivery and the Responses
to NGF Signaling of the miR-181d Machinery
The presynaptic localization of FMRP has been demonstrated in
the CNS (Antar et al., 2006; Klemmer et al., 2011). Our study re-
veals the importance of FMRP in the axonal delivery of miR-
181d and its targets. FMRP deficiency led to decreases in the
level of miR-181d, as well as those of Map1b and Calm1, in
the axons of primary sensory neurons. Consistent with these re-
sults, FMRP deficiency reduced the protein levels of MAP1B
and calmodulin in axons. Previous studies showed that FMRP
not only binds to the coding region or 50 UTR of mRNAs to block
their translation by stalling ribosomal translocation (Darnell
et al., 2011) but also interacts with Ago2 of the RISC in the
miRNA pathway (Muddashetty et al., 2011). Our study provides
evidence showing that miR-181d associates FMRP and re-
presses the translation of Map1b and Calm1. During the long-
distance axonal delivery of RNPs, FMRP may have dual roles
wherein it anchors Map1b and Calm1 to cytoskeletal motors
and functions in miR-181d-mediated RISC assembly to repress
gene translation. In addition, other pathways may be involved in
the axonal transport and local regulation of miR-181d and its
targets, because the transport of these transcripts is onlythors
partially affected by silencing FMRP, and approximately 42% of
miR-181d-positive granules, 53% of Map1b-positive granules,
and 36% of Calm1-positive granules contain FMRP in axons.
Furthermore, our biochemical evidence supporting the as-
sociation of FMRP with miR-181d in the cell bodies of DRG
neurons implies that mature miRNAs can be transported from
the cell body to supply the axonal abundance of miRNAs,
although pre-miRNAs have also been found in the axons, where
they generate mature miRNAs (Hancock et al., 2014). The pre-
cise molecular mechanisms underlying the FMRP-mediated
axonal delivery of pre- or mature miRNAs require further
investigation.
It has been established that target-derived neurotrophin is
required for the development of the peripheral nervous system
(Patel et al., 2000). NGF signaling is crucial for neuronal survival
and axon elongation in primary sensory neurons (Zhou et al.,
2004). From our study, NGF triggers the axonal translation of
Map1b and Calm1 in primary sensory neurons, indicating a
mechanism by which neurotrophin is linked to local microtubule
stabilization and calcium signaling. NT-3 is unable to affect the
axonal translation of Map1b and Calm1, indicating the effector
specificity of NGF-induced local translation. We provide a model
that demonstrates that, in the presence of a low concentration of
NGF or in its absence, the axonal translation of Map1b and
Calm1 is suppressed by both FMRP and miR-181d in FMRP
granules, whereas in the presence of 100 ng/ml NGF, Map1b
andCalm1 are released from FMRPgranules andmade available
for local translation. After 2 hr of NGF treatment, the re-associa-
tion of mRNAs with FMRP and the replenishment of mRNA-
bound FMRP were not able to supply the same amount of
released Map1b and Calm1. Because miR-181d is localized in
approximately 27% FMRP granules containing Map1b-30 UTR
and approximately 25% FMRP granules expressing Calm1-30
UTR in axons, the FMRP granules lack of miR-181d also contrib-
utes to NGF-induced local translation ofMap1b and Calm1. Un-
like the activity-dependent dissociation of mRNA and the RISC
from the FMRP complex in postsynaptic regions (Muddashetty
et al., 2011), miR-181d and Ago2 were still bound to the FMRP
complex in response to NGF signaling following the release of
Map1b and Calm1 for subsequent local translation. Signaling
by metabotropic glutamate receptors phosphorylates FMRP at
S499 and causes the release of mRNA and the RISC from the
FMRP complex (Muddashetty et al., 2011); however, NGF
signaling did not affect the phosphorylation of FMRP (data not
shown). The mechanisms by which various signals trigger
different elements to reorganize the FMRP complex require
further investigation. The present study substantially expands
our understanding of the molecular mechanisms of FMRP func-
tions by showing that it cooperates with miR-181d to target
Map1b and Calm1 in the axons of primary sensory neurons dur-
ing axon development.EXPERIMENTAL PROCEDURES
Animals, Plasmids, miRNA Mimics and Inhibitors, siRNAs, and TPs
All animal experiments were approved by the Committee of Use of Laboratory
Animals in the Institute of Biochemistry and Cell Biology, Chinese Academy of
Sciences. Descriptions of animal information and the synthesis of miRNACell Repmimics and inhibitors, siRNAs, and TPs are provided in the Supplemental
Experimental Procedures. The construction of plasmids Luc-MS2-24Xbs-
Map1b-30 UTR, Luc-MS2-24Xbs-Calm1-30 UTR, and other plasmids used
for luciferase reporter or shRNA assays and for FMRP and scrambles is also
provided in the Supplemental Experimental Procedures.
In Situ Hybridization
A detailed description of the procedure is provided in the Supplemental Exper-
imental Procedures. miR-181d and its targeting mRNAs were detected as re-
ported, with some modifications (Bicker et al., 2013; Li et al., 2012).
Live-Cell Imaging for mRNA Granules
Electroporated P14 DRG neurons at 4 days in vitro (DIV) were cultured on
glass-bottom dishes on a temperature-controlled workstation (37C) and
imaged using a UltraView Vox system (PerkinElmer). Regions of axon seg-
ments 100–150 mm from the cell body were selected, and 150 frames were
collected during a 5 min period. A kymograph was generated using ImageJ
1.4 software (NIH). The number and average velocity of RNA granules in a
kymograph were analyzed using Image-Pro Plus 5.1 software (Media
Cybernetics).
Axon Elongation Assay
A detailed description of the procedure is provided in the Supplemental Exper-
imental Procedures. We detected the axon growth rate as described previ-
ously, with some modifications (Ye et al., 2003). Briefly, in microfluidic cultures
of E13.5 DRG neurons at 7 DIV, the clear and longest distal axons in the axon
compartment were selected before and 48 hr after transfection with synthetic
siRNA, miRNA mimics, or an inhibitor. The increase in axon length over 48 hr
was analyzed using Neurolucida software (MBFBioscience). For NGF-induced
axon growth assays, axons from microfluidic chambers were monitored after
the indicated treatment or after AAV-mediated infection using 10 min intervals
for a total of 60 min using a live-cell imaging microscope, as previously re-
ported (Hengst et al., 2009). Axon length was analyzed using an ImageJ
plug-in (NIH).
RNA Immunoprecipitation
A detailed description of the procedure is provided in the Supplemental Exper-
imental Procedures. Briefly, the supernatants from DRG tissues and cultured
PC12 cells were pre-cleared using protein G sepharose and then incubated
with 5 mg FMRP antibody (Abcam) conjugated to immobilized beads, as pre-
viously reported (Zalfa et al., 2003). Total RNA was extracted from the beads
using Trizol and prepared for the subsequent detection of FMRP-associated
mRNAs and miRNAs.
Cell Culture, Transfection, and Immunostaining; RNA Extraction,
RT-PCR, and qPCR; Luciferase Reporter Assay; Immunoblotting;
Drug Treatment; and FRAP
Detailed descriptions of these procedures are provided in the Supplemental
Experimental Procedures.
Statistical Analysis
All data are presented as mean ± SEM. Statistical analyses were performed
using two-tailed paired Student’s t tests in Prism (GraphPad). Differences
were considered significant at p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and four tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.11.057.
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